|
Volumn 48, Issue 9, 2000, Pages 1249-1255
|
Antiandrogenic effect of 16-substituted, non-substituted and D-homopregnane derivatives
a a a a a b b |
Author keywords
5 reductase; D homo steroid; Seminal vesicle; Testosterone conversion
|
Indexed keywords
16ALPHA,17ALPHA EPOXY 20 ETHYLENEDIOXYPREGN 5 ENE 3BETA YL ACETATE;
16BETA METHYL 17ALPHA PROPIONYLOXYPREGNA 1,4,6 TRIENEDIENE 3,20 DIONE;
17ALPHA ACETOXY 16BETA METHYLPREGNA 1,4,6 TRIENE 3,20 DIONE;
17ALPHA ACETOXY 17BETA METHYL 16BETA PHENYL HOMOPREGNA 4,6 DIENE 3,17A DIONE;
17ALPHA ACETOXY 4 BROMOPREGNA 1,4 DIENE 3,20 DIONE;
17ALPHA HYDROXY 16BETA METHYLPREGNA 1,4,6 TRIENE 3,20 DIONE;
17ALPHA HYDROXY 17BETA METHYL 16BETA PHENYL HOMOPREGNA 4,6 DIENE 3,17A DIONE;
20 ETHYLENEDIOXY 16BETA PHENYLPREGN 5 ENE 3BETA,17ALPHA DIOL;
3BETA ACETOXY 16ALPHA,17ALPHA EPOXYPREGN 5 ENE 20 ONE;
3BETA ACETOXYPREGNA 5,16 DIEN 20 ONE;
3BETA HYDROXY 16ALPHA,17ALPHA EPOXYPREGN 5 ENE 20 ONE;
3BETA,17ALPHA DIHYDROXY 17BETA METHYL 16BETA PHENYL HOMOPREGN 5 EN 17A ONE;
ANDROGEN RECEPTOR;
ANDROSTANOLONE;
ANTIANDROGEN;
CYPROTERONE ACETATE;
FINASTERIDE;
HOMOPREGNANE DERIVATIVE;
M PROTEIN;
STEROID 5ALPHA REDUCTASE INHIBITOR;
TESTOSTERONE;
UNCLASSIFIED DRUG;
ANIMAL TISSUE;
ARTICLE;
CASTRATION;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG SYNTHESIS;
GONADECTOMY;
HAMSTER;
HORMONE INHIBITION;
HORMONE RECEPTOR INTERACTION;
MALE;
NONHUMAN;
ORGAN SIZE;
ORGAN WEIGHT;
PROTEIN CONTENT;
SEMINAL VESICLE;
SKIN NODULE;
TESTOSTERONE METABOLISM;
|
EID: 0033772709
PISSN: 00092363
EISSN: None
Source Type: Journal
DOI: 10.1248/cpb.48.1249 Document Type: Article |
Times cited : (15)
|
References (21)
|